
CareDx (CDNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $0.70 | $0.22 | 218.2 % |
| Q2 | Jul 30, 2026 | $0.37 | $0.20 | 85.0 % |
| Q1 | Apr 28, 2026 | $0.34 | $0.08 | 325.0 % |
| Q4 | Feb 24, 2026 | $0.12 | $0.23 | -47.8 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $139.36M | $122.04M | 14.2 % |
| Q2 | Jul 30, 2026 | $131.95M | $114.11M | 15.6 % |
| Q1 | Apr 28, 2026 | $117.70M | $105.50M | 11.6 % |
| Q4 | Feb 24, 2026 | $108.39M | $102.68M | 5.56 % |
CareDx (CDNA) last issued guidance on October 29, 2026 for fiscal year 2026. The company guided revenue in the range of $520M - $530M for the period.
Compared to prior guidance, CareDx raised its revenue forecast from a prior range of $490M - $500M.
CareDx has issued 27 guidance updates between January 9, 2023 and October 29, 2026. During this period, the company raised its outlook 14 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.22 | $0.20 | $0.08 | $0.23 |
| Actual | $0.70 | $0.37 | $0.34 | $0.12 |
| Surprise | +218.2% | +85.0% | +325.0% | -47.8% |
| Revenue | ||||
| Estimate | $122.0M | $114.1M | $105.5M | $102.7M |
| Actual | $139.4M | $131.9M | $117.7M | $108.4M |
| Surprise | +14.2% | +15.6% | +11.6% | +5.56% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.32 | $0.27 | $0.19 | $0.25 |
| Revenue | ||||
| Consensus | $135.8M | $131.0M | — | — |